Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
01/2003
01/02/2003EP0821719B1 Liquid crystal compounds having a chiral fluorinated terminal portion
01/02/2003EP0804431B9 GLYCOPROTEIN IIb/IIIa ANTAGONISTS
01/02/2003EP0751939B9 Naphthylamides as central nervous system agents
01/01/2003CN1388123A Chloropyrimidine intermediate
01/01/2003CN1097587C Dihydrobenzofuran and related compound used as anti-inflammatory agent
12/2002
12/31/2002US6500959 Pyrrolidine derivatives and processes for preparing same
12/31/2002US6500950 Benzylidenepyrazolones, their preparation and use
12/31/2002US6500854 Chondrongenesis promotors and indolin-2-one derivatives
12/31/2002US6500849 Administering antiinflammatory, antiproliferative, nootropic or antigrowth agents, such as 6-(1-dodecynyl)-2-pyridine-carboxaldehyde and enantiomorphs to mammals; alzheimers disease
12/31/2002US6500848 Pesticides
12/31/2002US6500846 2-(4-chlorophenyl)-7-methoxychromen-4-one, as cyclin-dependent kinase inhibitors, used as anticarcinogenic agents or for prophylaxis of neurodegenerative disease
12/31/2002US6500842 N-((4-chlorophenyl)methyl)-8-hydroxy-7-quinolinecarboxamide administered as viricides against herpes virus
12/31/2002US6500841 Inhibitors of farnesyl-protein transferase
12/31/2002US6500832 Administering enzyme inhibitors as viricides for prophylaxis of viral diseases such as aquired immune deficiency syndrome
12/31/2002US6500830 Conversion of modification D to modification A of doxazosin mesylate
12/31/2002US6500822 Benzocycloalkylenylamine derivatives as muscarinic receptor antagonists
12/31/2002US6500303 Inhibition of pulp and paper yellowing using nitroxides, hydroxylamines and other coadditives
12/31/2002CA2227814C Substituted benzylaminopiperidine compounds
12/31/2002CA2075586C Salicyloyl(thio)ether derivatives, their preparation and intermediates for ther preparation
12/27/2002WO2002103008A2 Templated molecules and methods for using such molecules
12/27/2002WO2002102820A1 Nucleoside derivatives for library preparation
12/27/2002WO2002102798A1 Uracil derivative and herbicide composition
12/27/2002WO2002102795A1 Fluorescent probes for zinc
12/27/2002WO2002102794A2 Polymorphic forms of 1-'4-(5-cyanoindol-3-yl)butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride
12/27/2002WO2002102790A1 N-formyl hydroxylamine compounds as inhibitors of pdf
12/27/2002WO2002102782A2 QUINAZOLINE DERIVATIVES which PROMOTE THE RELEASE OF PARATHYROID_HORMONE
12/27/2002WO2002102778A1 Phenylpyridine carbonyl piperazine derivative
12/27/2002WO2002102382A1 A PROCESS FOR PREPARING PAROXETINE HCl WHICH LIMITS FORMATION OF PINK COLORED COMPOUNDS
12/27/2002WO2002102372A1 Gem-disubstituted cyclohexane derivatives and their use as therapeutic agents
12/27/2002WO2002102359A2 Alkylidene pyrazolidinedione derivatives and use for treating diabetes and obesity
12/27/2002WO2002088117A3 Method for producing 2-[-5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane
12/27/2002WO2002046181A3 Abca-1 elevating compounds against coronary artery disease or atherosclerosis
12/27/2002CA2782868A1 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride
12/27/2002CA2782865A1 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride
12/27/2002CA2782862A1 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride
12/27/2002CA2782857A1 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride
12/27/2002CA2782791A1 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride
12/27/2002CA2782761A1 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride
12/27/2002CA2782628A1 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride
12/27/2002CA2782623A1 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride
12/27/2002CA2782615A1 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride
12/27/2002CA2782521A1 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl) piperazine hydrochloride
12/27/2002CA2782519A1 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl) piperazine hydrochloride
12/27/2002CA2782517A1 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl) piperazine hydrochloride
12/27/2002CA2782515A1 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride
12/27/2002CA2782494A1 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride
12/27/2002CA2451524A1 Templated molecules and methods for using such molecules
12/27/2002CA2449212A1 Alkylidene pyrazolidinedione derivatives and use for treating diabetes and obesity
12/27/2002CA2448526A1 N-formyl hydroxylamine compounds as inhibitors of pdf
12/27/2002CA2448298A1 Phenylpyridine carbonyl piperazine derivative
12/27/2002CA2447808A1 A process for preparing paroxetine hci which limits formation of pink colored compounds
12/26/2002US20020198387 Reacting N-alkylpiperidine with a haloformic acid ester to prepare an alkoxycarbonylpiperidine, hydrolyzing
12/26/2002US20020198246 Agent for preventing and/or treating sinusitis
12/26/2002US20020198219 2-pyridinamine compositions and related methods
12/26/2002US20020198216 Novel farnesyl protein transferase inhibitors as antitumor agents
12/26/2002US20020198198 Spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
12/26/2002US20020198195 New oxybenzamide derivatives useful for inhibiting factor Xa or VIIa
12/26/2002US20020198194 Neuropeptide Y (NPY) antagonists for the treatment or prevention of arthritis, cardiovascular diseases, diabetes, renal failure, eating disorders, or obesity
12/26/2002US20020198184 Matrix metalloproteinase inhibitor is useful as an anticancer agent, angiogenesis inhibitor, a tumor cell infiltration inhibitor or a tumor metastasis inhibitor; inflammatory diseases, osteoarthritis, rheumatoid arthritis
12/26/2002US20020198173 Viricides for treating HIV and hepatitis virus
12/26/2002US20020198171 Administering to a hepatitis B infection patient an effective treatment amount of a 2'fluoro- beta -D-nucleoside or salts(containing purine or pyrimidine base)
12/26/2002US20020197562 Photochromic compositions and photochromic ophthalmic articles
12/26/2002US20020197561 Information layer comprises a light-absorbent compound that is a dye which cyclizes thermally
12/26/2002US20020195585 Liquid crystalline materials containing perfluoroalkyl and alkenyl tail groups
12/25/2002CN1387528A Heterocyclic substd, pyrazolones
12/25/2002CN1387526A Cyclopropanes as CGRP antagonists, medicaments contg. said compounds and method for production thereof
12/25/2002CN1387517A 5-aryl-1H-1,2,4-triazole compounds as inhibitors of cyclooxygenase-2 and pharmaceutical compositions contg. them
12/25/2002CN1387516A Substd. 5-benzyl-2,4-diaminopyrimidines
12/25/2002CN1387514A Aromatic sulfone hydroxamic acid metalloprotease inhibitor
12/25/2002CN1387512A Positive modulators for nicotinic receptor agonists
12/25/2002CN1097052C Process for production of amidinoindole derivs, and salts thereof
12/25/2002CN1097051C N-heteroaryl-pyridinesulfonamide derivs. and their use as endotheliin antagonists
12/25/2002CN1097049C Processes for preparing intermediate product used in method of diastereoselective synthesis of nucleosides
12/25/2002CN1097048C Photo-cross-linkable 1,4-dioxan-2,3-diyl derivs.
12/25/2002CN1097044C Taxane derivs. and drugs contg. same
12/24/2002US6498347 Infrared imager using room temperature capacitance sensor
12/24/2002US6498252 Pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents containing these compounds
12/24/2002US6498251 Tetrahydrobenzindole derivatives
12/24/2002US6498176 Inhibiting tumor growth via inhibition of tumor-related angiogenesis
12/24/2002US6498172 Prostaglandin agonists and their use to treat bone disorders
12/24/2002US6498170 4-((2s)-3-(1-(4-butoxy-benzenesulfonyl)-azetidin-3-ylamino)-2 -hydroxy- propoxy)-phenol for example; hypoglycemic agent; increasing lean meat to fat ratio in mammals
12/24/2002US6498168 Muscarinic antagonists
12/24/2002US6498165 Pyrimidine compounds; prophylaxis and treatment of such as immune diseases, hyperproliferative disorders, cancer, angiogensis, atheroscelerosis, graft rejection, rheumatoid arthritis, psoriasis
12/24/2002US6498160 For therapy of emphysema, chronic bronchitis, asthma and allergic rhinitis
12/24/2002US6498158 Il-5 inhibiting 6-azauracil derivatives
12/24/2002US6498125 Pyridine ketones useful as herbicides
12/24/2002US6497730 Cationic methylenedioxy benzenes, their use for oxidation dyeing of keratin fibers, dyeing compositions and methods
12/19/2002WO2002100886A1 Pyrrolidin-2-one derivatives as inhibitors of factor xa
12/19/2002WO2002100853A1 Pyrazole derivatives as hiv reverse transcriptase inhibitors
12/19/2002WO2002100849A2 Novel nitriles useful as reversible inhibitors of cysteine proteases
12/19/2002WO2002100846A1 Compounds and methods for the treatment or prevention of flavivirus infections
12/19/2002WO2002100845A1 Hv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
12/19/2002WO2002100844A2 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
12/19/2002WO2002100838A1 2,5-diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylpyrimidines as crf1 receptor modulators
12/19/2002WO2002100836A2 Compounds, compositions and methods for modulating beta-amyloid production
12/19/2002WO2002100833A1 Rho KINASE INHIBITORS
12/19/2002WO2002100829A2 Process for the preparation of paroxetine substantially free of alkoxy impurities
12/19/2002WO2002100825A2 Anthranilic acid amides with a heteroarylsulfonyl side chain, and use thereof as antiarrhythmic active substances
12/19/2002WO2002100403A1 Modulators of peroxisome proliferator activated receptors (ppar)
12/19/2002WO2002100401A1 Soluble cdk-inhibitory indirubin derivatives
1 ... 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 ... 694